+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Virtual Diagnostics Market: Focus on Type of Diagnosis, End User, Region, Patent Scenario and Competitive Landscape - Analysis and Forecast, 2019-2030

  • ID: 5010736
  • Report
  • March 2020
  • Region: Global
  • 157 Pages
  • BIS Research
1 of 6

Enquire about COVID-19 updates for this product.

Enquire Now
Global Virtual Diagnostics Market to Grow at a CAGR of 15.52% from 2019-2030

FEATURED COMPANIES

  • AliveCor Inc.
  • Cardiologs Technologies
  • Healthy.io Ltd.
  • Hill-Rom Holdings, Inc.
  • Medtronic Plc
  • Phelcom Technologies
  • MORE

Key Questions Answered in the Report:

  • What are the key features of virtual diagnostics and what are the different technologies of virtual diagnostics offered in the market?
  • What are the major market drivers, restraints, and opportunities in the global virtual diagnostics market?
  • What are the expected regional and global scenarios of the virtual diagnostics market, and the growth potential of each country in various regions?
  • What are the key development strategies being implemented by the key players in this market?
  • What are the key regulations governing the manufacturing and commercialization of various products in the global virtual diagnostics market?
  • What is the expected growth of the virtual diagnostics market in the forecast period 2019-2030?
  • What are the leading companies dominating the global virtual diagnostics market?
  • How are the key players of the virtual diagnostics market expected to grow in the forecast period?
  • What was the market value of the leading segments of the global virtual diagnostics market in 2018?
  • How is each segment of the global virtual diagnostics market expected to grow during the forecast period, and what is the estimated revenue generation by each of the segments by the end of 2030?
  • Which region is expected to contribute the highest sales in the global virtual diagnostics market during the forecast period?

The global virtual diagnostics market industry analysis projects the market to grow at a significant CAGR of 15.52% during the forecast period, 2019-2030. The global virtual diagnostics market generated $425.6 million in revenue in 2018, in terms of value.

The market growth in the global virtual diagnostics market can primarily be attributed to factors such as increasing rising awareness for early disease diagnosis and increasing demand for accessible and affordable diagnostics. However, there are significant challenges that are restraining the market growth. These challenges include low accuracy within the virtual diagnosis and increasing privacy concerns among the people worldwide.

Expert Quote

“The technological breakthroughs in artificial intelligence and machine learning technologies along with high adoption rate of smartphones within various regions of the world have paved a way for the growth of global virtual diagnostics market in the forecast period of 2019-2030”

Scope of the Market Intelligence on Global Virtual Diagnostics Market

The research report on the global virtual diagnostics market provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the global virtual diagnostics market. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying segment, and company, as well as other vital information with respect to global virtual diagnostics market.

Market Segmentation

  • The global virtual diagnostics market is segmented on the basis of the type of diagnosis, into Gastrointestinal, Cardiology, Pathology, Ophthalmology, and others.
  • The global virtual diagnostics market is further segmented by end-user into hospitals, specialty clinics, and ambulatory centers and others.
  • The global virtual diagnostics market on the basis of region is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. The potential of the market with respect to different countries within these regions has also been provided.

Key Companies in the Global Virtual Diagnostics Market

The key manufacturers who have been contributing significantly to the global virtual diagnostics market include Uber Diagnostics, CapsoVision Inc., Cardiologs Technologies, Healthy.io Ltd, IDx Technologies Inc., Monitored Therapeutics, Inc., Olympus  Corporation, Phelcom Technologies, Sight Diagnostics, Medtronic Plc, hearX IP (Pty) Ltd, AliveCor, Inc., ResApp Health Limited, and SkinVision among others.

Enterprise License customers will receive an Excel spreadsheet containing additional data.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • AliveCor Inc.
  • Cardiologs Technologies
  • Healthy.io Ltd.
  • Hill-Rom Holdings, Inc.
  • Medtronic Plc
  • Phelcom Technologies
  • MORE

Executive Summary

1 Product Definition

2 Scope of Work
2.1 Report Coverage
2.2 Exclusions and Inclusion Criteria of the Report
2.2.1 Exclusion Criteria
2.2.2 Inclusion Criteria
2.3 Key Questions Answered in the Report

3 Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Data Sources Categorization
3.5 Companies Profiled in the Report
3.6 Assumptions and Limitations

4 Industry Analysis
4.1 Industry Structure
4.1.1 Virtual Diagnostics Vendors
4.1.2 Contract Manufacturers
4.1.3 Distributors
4.2 Legal & Regulatory Framework
4.2.1 North America
4.2.1.1 Regulatory Requirements in the U.S.
4.2.1.2 Regulatory Requirements in Canada
4.2.2 Europe
4.2.3 Other Countries
4.3 Associations, Consortiums, and Regulatory Bodies
4.4 Patent Analysis
4.4.1 Patent Filing Trend, January 2015 to December 2019
4.4.2 Awaited Technologies

5 Competitive Landscape
5.1 Overview
5.2 Key Strategies and Developments
5.2.1 Regulatory and Legal Activities
5.2.2 Partnerships, Alliances, Agreements, and Business Expansions
5.2.3 New Offerings
5.2.4 Funding Activities
5.3 Growth Share Analysis
5.3.1 Growth Share Matrix (by Type of Diagnosis)
5.3.2 Growth Share Matrix (by End User)
5.3.3 Growth Share Matrix (by Region)
5.4 Product Mapping Analysis

6 Global Virtual Diagnostics Market Scenario
6.1 Limitations and Assumptions
6.2 Key Findings
6.3 Global Virtual Diagnostics Market and Forecast (2019-2030)
6.3.1 Market Drivers
6.3.1.1 Advancements in Application of Biosensor Technology
6.3.1.2 Rising Gastrointestinal Disorders
6.3.1.3 Technological Breakthroughs in Diagnostic Testing Techniques
6.3.1.4 Increasing Demand for Smartphone-Based Diagnostics
6.3.1.5 High Accessibility to Remote Areas
6.3.1.6 Increasing Awareness in Disease Diagnostics
6.3.1.7 Improved Microscopic Imaging in Smartphones
6.3.2 Market Restraints
6.3.2.1 Hindrance in Privacy through Virtual Diagnostic Methods
6.3.2.2 Risk of Low Accuracy in Diagnosis
6.3.3 Market Opportunities
6.3.3.1 Large Scope of Cross Vertical Collaboration
6.3.3.2 Strong Pipeline of Virtual Diagnostic Products and Platforms

7 Global Virtual Diagnostics Market (by Type of Diagnosis)
7.1 Overview
7.2 Gastrointestinal Virtual Diagnostics Market
7.3 Ophthalmology Virtual Diagnostics Market
7.4 Cardiology Virtual Diagnostics Market
7.5 Pathology Virtual Diagnostics Market
7.6 Others Virtual Diagnostics Market

8 Global Virtual Diagnostics Market (by End User)
8.1 Overview
8.2 Hospitals
8.3 Specialty Clinics and Ambulatory Surgical Centers
8.4 Others (Homecare and Research Institutes)

9 Global Virtual Diagnostics Market (by Region)
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 Australia
9.4.4 South Korea
9.4.5 India
9.4.6 Rest-of-Asia-Pacific
9.5 Latin America, Middle East, and Africa

10 Company Profiles
10.1 AliveCor Inc.
10.1.1 Company Overview
10.1.2 Role of Alivecor, Inc. in the Global Virtual Diagnostics Market
10.1.3 SWOT Analysis
10.2 Cardiologs Technologies
10.2.1 Company Overview
10.2.2 Role of Cardiologs Technologies in the Global Virtual Diagnostics Market
10.2.3 SWOT Analysis
10.3 CapsoVision, Inc.
10.3.1 Company Overview
10.3.2 Role of CapsoVision, Inc. in the Global Virtual Diagnostics Market
10.3.3 SWOT Analysis
10.4 Eyenuk, Inc.
10.4.1 Company Overview
10.4.2 Role of Eyenuk Inc. in the Global Virtual Diagnostics Market
10.4.3 SWOT Analysis
10.5 Healthy.io Ltd.
10.5.1 Company Overview
10.5.2 Role of Healthy.io Ltd. in the Global Virtual Diagnostics Market
10.5.3 SWOT Analysis
10.6 hearX IP (Pty) Ltd.
10.6.1 Company Overview
10.6.2 Role of hearX IP (Pty) Ltd. in the Global Virtual Diagnostics Market
10.6.3 SWOT Analysis
10.7 Hill-Rom Holdings, Inc.
10.7.1 Company Overview
10.7.2 Role of Hill-Rom Holdings, Inc in the Global Virtual Diagnostics Market
10.7.3 Financials
10.7.4 SWOT Analysis
10.8 IDx Technologies Inc.
10.8.1 Company Overview
10.8.2 Role of IDx Technologies Inc. in the Global Virtual Diagnostics Market
10.8.3 SWOT Analysis
10.9 Medtronic Plc.
10.9.1 Company Overview
10.9.2 Role of Medtronic Plc. in the Global Virtual Diagnostics Market
10.9.3 Financials
10.9.4 SWOT Analysis
10.10   Monitored Therapeutics Inc.
10.10.1 Company Overview
10.10.2 Role of Monitored Therapeutics Inc. in the Global Virtual Diagnostics Market
10.10.3 SWOT Analysis
10.11   Olympus Corporation
10.11.1 Company Overview
10.11.2 Role of Olympus Corporation in the Global Virtual Diagnostics Market
10.11.3 Financials
10.11.4 SWOT Analysis
10.12   Phelcom Technologies
10.12.1 Company Overview
10.12.2 Role of Phelcom Technologies in the Global Virtual Diagnostics Market
10.12.3 SWOT Analysis
10.13   ResApp Health Limited
10.13.1 Company Overview
10.13.2 Role of ResApp Health Limited in the Global Virtual Diagnostics Market
10.13.3 SWOT Analysis
10.14   Sight Diagnostics
10.14.1 Company Overview
10.14.2 Role of Sight Diagnostics in the Global Virtual Diagnostics Market
10.14.3 SWOT Analysis
10.15   SkinVision
10.15.1 Company Overview
10.15.2 Role of SkinVision in the Global Virtual Diagnostics Market
10.15.3 SWOT Analysis

List of Tables
Table 4.1: List of Associations/Consortiums/Regulatory Bodies with Year of Establishment and Headquarters
Table 5.1: Company Product Mapping Analysis
Table 6.1: Impact of Market Drivers, 2019-2030
Table 6.2: Impact of Market Restraints, 2019-2030

List of Figures
Figure 1: Global Virtual Diagnostics Market Growth, 2018-2030
Figure 2: Impact Analysis for Key Market Drivers and Restraints, 2019-2030
Figure 3: Share of Key Developments and Strategies, January 2016-January 2020
Figure 4: Global Virtual Diagnostics Market (by Region), 2018-2030
Figure 5: Global Virtual Diagnostics Market (by Type of Diagnosis and by End User), 2018 and 2030
Figure 2.1: Global Virtual Diagnostics Market Segmentation
Figure 3.1: Global Virtual Diagnostics Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Shares of Key Companies Profiled
Figure 3.5: Assumptions and Limitations
Figure 4.1: Number of Patents Filed, January 2015 to December 2019
Figure 5.1: Share of Key Developments and Strategies, January 2016 to January 2020
Figure 5.2: Analysis of Key Developmental Strategies, by Year, January 2016 to  January 2020
Figure 5.3: Regulatory and Legal (By Company), January 2016 to January 2020
Figure 5.4: Partnerships, Alliances, and Business Expansions (by Company),  January 2016 to January 2020
Figure 5.5: New Offerings (by Company), January 2016 to January 2020
Figure 5.6: Funding Activities (by Company), January 2016 to January 2020
Figure 5.7: Growth Share Matrix for Global Virtual Diagnostics Market (by Type of Diagnosis), 2019-2030
Figure 5.8: Growth Share Matrix for Global Virtual Diagnostics Market (by End User), 2019-2030
Figure 5.9: Growth Share Matrix for Global Virtual Diagnostics Market (by Region),  2019-2030
Figure 6.1: Global Virtual Diagnostics Market Incremental Growth Opportunity, 2018-2030
Figure 7.1: Global Virtual Diagnostics Market Share (by Type of Diagnosis), 2018 and 2030
Figure 7.2: Global Virtual Diagnostics Market (by Type of Diagnosis), 2018-2030
Figure 7.3: Global Gastrointestinal Virtual Diagnostics Market, 2018-2030
Figure 7.4: Global Ophthalmology Virtual Diagnostics Market, 2018-2030
Figure 7.5: Global Cardiology Virtual Diagnostics Market, 2018-2030
Figure 7.6: Global Pathology Virtual Diagnostics Market, 2018-2030
Figure 7.7: Global Virtual Diagnostics Market for Others Segment, 2018-2030
Figure 8.1: Global Virtual Diagnostics Market Share (by End User), 2018 and 2030
Figure 8.2: Global Virtual Diagnostics Market (by End User), 2018-2030
Figure 8.3: Global Virtual Diagnostics Market for Hospital Segment, 2018-2030
Figure 8.4: Global Virtual Diagnostics Market for Speciality Clinics and Ambulatory Surgical Centers, 2018-2030
Figure 8.5: Global Virtual Diagnostics Market for Others Segment, 2018-2030
Figure 9.1: Global Virtual Diagnostics Market (by Region), 2018-2030
Figure 9.2: North America Virtual Diagnostics Market Share (by Country), 2018 and 2030
Figure 9.3: North America Virtual Diagnostics Market, 2018-2030
Figure 9.4: North America: Market Dynamics
Figure 9.5: U.S. Virtual Diagnostics Market, 2018-2030
Figure 9.6: Canada Virtual Diagnostics Market, 2018-2030
Figure 9.7: Europe Virtual Diagnostics Market Share (by Country), 2018 and 2030
Figure 9.8: Europe Virtual Diagnostics Market, 2018-2030
Figure 9.9: Europe: Market Dynamics
Figure 9.10: Germany Virtual Diagnostics Market, 2018-2030
Figure 9.11: France Virtual Diagnostics Market, 2018-2030
Figure 9.12: U.K. Virtual Diagnostics Market, 2018-2030
Figure 9.13: Italy Virtual Diagnostics Market, 2018-2030
Figure 9.14: Spain Virtual Diagnostics Market, 2018-2030
Figure 9.15: Rest-of-Europe Virtual Diagnostics Market, 2018-2030
Figure 9.16: Asia-Pacific Virtual Diagnostics Market Share (by Country), 2018 and 2030
Figure 9.17: Asia-Pacific Virtual Diagnostics Market,2018-2030
Figure 9.18: Asia-Pacific: Market Dynamics
Figure 9.19: Japan Virtual Diagnostics Market, 2018-2030
Figure 9.20: China Virtual Diagnostics Market, 2018-2030
Figure 9.21: Australia Virtual Diagnostics Market, 2018-2030
Figure 9.22: South Korea Virtual Diagnostics Market, 2018-2030
Figure 9.23: India Virtual Diagnostics Market, 2018-2030
Figure 9.24: Rest of Asia-Pacific Virtual Diagnostics Market, 2018-2030
Figure 9.25: Latin America, Middle East, and Africa Virtual Diagnostics Market, 2018-2030
Figure 9.26: Middle East, Latin America, Middle East, and Africa: Market Dynamics
Figure 10.1: AliveCor, Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.2: AliveCor, Inc.: SWOT Analysis
Figure 10.3: Cardiologs Technologies: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.4: Cardiologs Technologies: SWOT Analysis
Figure 10.5: CapsoVision Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.6: CapsoVision, Inc.: SWOT Analysis
Figure 10.7: Eyenuk Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.8: Eyenuk Inc.: SWOT Analysis
Figure 10.9: Healthy.io Ltd.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.10: Healthy.io. Ltd.: SWOT Analysis
Figure 10.11: hearX IP (Pty) Ltd.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.12: hearX IP (Pty) Ltd.: SWOT Analysis
Figure 10.13: Hill-Rom Holdings, Inc.: Product Portfolio for Global Virtual  Diagnostics Market
Figure 10.14: Hill-Rom Holdings, Inc.: Overall Financials, 2017-2019
Figure 10.15: Hill-Rom Holdings, Inc.: Revenue (by Segment), 2017-2019
Figure 10.16: Hill-Rom Holdings, Inc.: Revenue (by Region), 2017-2019
Figure 10.17: Hill-Rom Holdings, Inc.: R&D Expenditure, 2017-2019
Figure 10.18: Hill-Rom Holdings, Inc.: SWOT Analysis
Figure 10.19: IDx Technologies Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.20: IDx Technologies Inc.: SWOT Analysis
Figure 10.21: Medtronic Plc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.22: Medtronic Plc: Overall Financials, 2017-2019
Figure 10.23: Medtronic Plc: Revenue (by Segment), 2017-2019
Figure 10.24: Medtronic Plc: Revenue (by Region), 2017-2019
Figure 10.25: Medtronic Plc: R&D Expenditure, 2017-2019
Figure 10.26: Medtronic Plc.: SWOT Analysis
Figure 10.27: Monitored Therapeutics Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.28: Monitored Therapeutics, Inc.: SWOT Analysis
Figure 10.29: Olympus Corporation: Product Portfolio for Global Virtual  Diagnostics Market
Figure 10.30: Olympus Corporation: Overall Financials, 2016-2018
Figure 10.31: Olympus Corporation: Revenue (by Segment), 2016-2018
Figure 10.32: Olympus Corporation: Revenue (by Region), 2016-2018
Figure 10.33: Olympus Corporation: R&D Expenditure, 2016-2018
Figure 10.34: Olympus Corporation: SWOT Analysis
Figure 10.35: Phelcom Technologies: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.36: Phelcom Technologies: SWOT Analysis
Figure 10.37: ResApp Health Limited: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.38: ResApp Health Limited: SWOT Analysis
Figure 10.39: Sight Diagnostics: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.40: Sight Diagnostics: SWOT Analysis
Figure 10.41: SkinVision: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.42: SkinVision: SWOT Analysis

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • AliveCor Inc.
  • Cardiologs Technologies
  • Healthy.io Ltd.
  • Hill-Rom Holdings, Inc.
  • Medtronic Plc
  • Phelcom Technologies
  • MORE

Globally, the healthcare system is facing the challenge and burden of limited facilities for diagnosis, unevenly distributed in various regions of the world along with low accuracy of diagnosis being performed pertaining to human error. To tackle such issues, the researchers have come across cloud and mobile technologies for performing automated medical diagnoses. Such technologies can be made available in every part of the world with the help of the internet and can thus improve coverage and reduce the cost of diagnosis.

The factors such as the rising diagnostic expenditures, poor health conditions, lack of physicians, and medical staff, and the increasing incidences of chronic health conditions have driven the virtual diagnostics market. Attributed to this, leading manufacturers in the market have developed artificial intelligence and machine learning based-tools, which are often incorporated in the smartphones and platforms that are used to mimic human cognitive behaviors and to analyze the complex medical data available from the healthcare settings. To meet the demand for such products, numerous established, as well as emerging companies, are venturing into the virtual diagnostics market in order to earn huge profits and to make the maximum use of technologies such as AI and machine learning to incorporate important advances in the field of diagnostics.

According to the market intelligence report, titled 'Global Virtual Diagnostics Market - Analysis and Forecast, 2019-2030', the global virtual diagnostics market was valued at $425.6 million in 2018 and is projected to grow at a CAGR of 15.52% during the forecast period from 2019 to 2030.

Note: Product cover images may vary from those shown
5 of 6
  • AliveCor Inc.
  • Cardiologs Technologies
  • CapsoVision, Inc.
  • Eyenuk, Inc.
  • Healthy.io Ltd.
  • hearX IP (Pty) Ltd.
  • Hill-Rom Holdings, Inc.
  • IDx Technologies Inc.
  • Medtronic Plc
  • Monitored Therapeutics Inc.
  • Olympus Corporation
  • Phelcom Technologies
  • ResApp Health Limited
  • Sight Diagnostics
  • SkinVision
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll